Current Drug Safety
Title:Editorial: Adverse Drug Reactions – Preventable or Unexpected?
Volume: 9 Issue: 1
Author(s): Seetal Dodd
Affiliation:
Export Options
About this article
Cite this article as:
Dodd Seetal, Editorial: Adverse Drug Reactions – Preventable or Unexpected?, Current Drug Safety 2014; 9 (1) . https://dx.doi.org/10.2174/157488630901140224100800
DOI https://dx.doi.org/10.2174/157488630901140224100800 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
54
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacokinetics and Disposition of Various Drug Loaded Liposomes
Current Drug Metabolism Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Anti-α4β1 Integrin Antibodies Attenuated Brain Inflammatory Changes in a Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Primary and Secondary B-Cell Responses to Pulmonary Virus Infection
Infectious Disorders - Drug Targets Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment
Current Neuropharmacology Rituximab Treatment Modulates the Release of Hydrogen Peroxide and the Production of Proinflammatory Cytokines by Monocyte at the Onset of Type 1 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Diagnosis and Therapy of Autoimmune Hepatitis
Mini-Reviews in Medicinal Chemistry Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two Parts
Endocrine, Metabolic & Immune Disorders - Drug Targets Sweet’s Syndrome: An Update
Current Pediatric Reviews Natural Sesquiterpene Lactones in the Prevention and Treatment of Inflammatory Disorders and cancer: A Systematic Study of this Emerging Therapeutic Approach based on Chemical and Pharmacological Aspect
Letters in Drug Design & Discovery Nitric Oxide: Cancer Target or Anticancer Agent?
Current Cancer Drug Targets In silico Structural and Functional Analysis of Arabidopsis thaliana’s XPB Homologs
Current Proteomics Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Author Index To Volume 5
Inflammation & Allergy - Drug Targets (Discontinued) Application of G-CSF in Congestive Heart Failure Treatment
Current Cardiology Reviews Localized Nano-mediated Interleukin-12 Gene Therapy: Promising Candidate for Cancer Immunotherapeutics
Current Cancer Drug Targets Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review
Current Drug Targets Pro-Oxidant Natural Products as Anticancer Agents
Current Drug Targets <i>In Silico</i> Evaluation of Various Signal Peptides to Improve Secretion of Humulin Protein in <i>E. coli</i> Host
Current Proteomics